Free Trial
NASDAQ:BFRIW

Biofrontera (BFRIW) Stock Price, News & Analysis

$0.07
-0.12 (-64.59%)
(As of 11/1/2024 ET)

About Biofrontera Stock (NASDAQ:BFRIW)

Key Stats

Today's Range
$0.04
$0.18
50-Day Range
$0.02
$0.19
52-Week Range
$0.01
$0.23
Volume
48,919 shs
Average Volume
12,391 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Receive BFRIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter.

BFRIW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BFRIW Stock Analysis - Frequently Asked Questions

Biofrontera's stock was trading at $0.01 on January 1st, 2024. Since then, BFRIW shares have increased by 557.8% and is now trading at $0.0658.
View the best growth stocks for 2024 here
.

Shares of BFRIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BFRIW
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$35.24 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:BFRIW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners